NCT03769025View on ClinicalTrials.gov

Remote Observed Dosing of Suboxone to Improve Clinical Practice

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

16

Participants

Timeline

Start Date

April 1, 2019

Primary Completion Date

May 31, 2022

Study Completion Date

July 1, 2022

Conditions
Opioid-use DisorderOpioid DependenceOpiate Dependence
Interventions
BEHAVIORAL

Suboxone Remote Observed Dosing

The remote observed dosing group will use the provided smartphone to video record themselves taking their Suboxone dose each day

OTHER

Suboxone Attention Control

Attention control group will send a text message daily confirming that they have taken their Suboxone dose

Trial Locations (1)

19104

University of Pennsylvania Treatment Research Center, Philadelphia

All Listed Sponsors
collaborator

National Institute on Drug Abuse (NIDA)

NIH

lead

University of Pennsylvania

OTHER

NCT03769025 - Remote Observed Dosing of Suboxone to Improve Clinical Practice | Biotech Hunter | Biotech Hunter